Trending Clinical Topics for January 2018

Ryan Syrek

Disclosures

January 26, 2018

Clinical Trend of the Week (December 30 – January 5): Giapreza

Approval of a new drug by the US Food and Drug Administration (FDA) is once again responsible for the top search term of the week. In late December, the FDA approved angiotensin II injection for intravenous infusion (Giapreza) in adult patients in septic or other distributive shock. In a clinical trial, the injection was associated with increased blood pressure when combined with conventional treatments. However, the drug is associated with arterial and deep venous thrombosis, necessitating the use of prophylactic treatment for blood clots. Giapreza’s approval and ongoing controversy surrounding proposed guidelines have kept sepsis in the spotlight, where it is likely to remain for some time.

For more information on septic shock, read here

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....